Genetic polymorphisms in RAD23B and XPC modulate DNA repair capacity and breast cancer risk in puerto rican women

Molecular Carcinogenesis

Volumn 52, Issue SUPPL1, 2013, Pages 127-138

  Pérez Mayoral, Julyann ^a   Pacheco Torres, Alba L ^a   Morales, Luisa ^a   Acosta Rodríguez, Heidi ^a   Matta, Jaime L ^a   Dutil, Julie ^a  

^a PONCE SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Breast cancer genetics; DNA repair; Nucleotide excision repair

Indexed keywords

DNA; ONCOPROTEIN; RAD23B PROTEIN; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; EXCISION REPAIR; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HOST CELL; HUMAN; MAJOR CLINICAL STUDY; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUERTO RICO; SINGLE NUCLEOTIDE POLYMORPHISM; ULTRAVIOLET RADIATION;

BREAST CANCER GENETICS; DNA REPAIR; NUCLEOTIDE EXCISION REPAIR;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PUERTO RICO; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 84886287642     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22056     Document Type: Article

References (72)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. CA Cancer J Clin 2010; 60:277-300.
2. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004; 101:3-27.
3. Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M. Trends in breast cancer by race and ethnicity. CA Cancer J Clin 2003; 53:342-355.
4. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 2003; 163:49-56.
5. Torres-Cintrón M, Ortiz AP, Javier Pérez-Irizarry J, et al. Incidence and mortality of the leading cancer types in Puerto Rico: 1987-2004. P R Health Sci J 2010; 29:317-329.
6. Nazario CM, Figueroa-Valles N, Rosario RV. Breast cancer patterns and lifetime risk of developing breast cancer among Puerto Rican females. P R Health Sci J 2000; 19:7-13.
7. Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: Factors influencing differences in incidence and outcome. J Natl Cancer Inst 2005; 97:439-448.
8. Fejerman L, Haiman CA, Reich D, et al. An admixture scan in 1, 484 African American women with breast cancer. Cancer Epidemiol Biomarkers Prev 2009; 18:3110-3117.
9. Willett WC. Diet breast cancer. J Intern Med 2001; 249:395-411.
10. Dumitrescu RG, Cotarla I. Understanding breast cancer risk-Where do we stand in 2005? J Cell Mol Med 2005; 9:208-221.
11. Gerber B, Müller H, Reimer T, Krause A, Friese K. Nutrition and lifestyle factors on the risk of developing breast cancer. Breast Cancer Res Treat 2003; 79:265-276.
12. Claus EB, Schildkraut JM, Thompson WD, Risch NJ. The genetic attributable risk of breast and ovarian cancer. Cancer 1996; 77:2318-2324.
13. Walsh T, King M-C. Ten genes for inherited breast cancer. Cancer Cell 2007; 11:103-105.
14. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, et al. Cancer as a complex phenotype: Pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004; 1:e65.
15. Cannon-Albright LA, Thomas A, Goldgar DE, et al. Familiality of cancer in Utah. Cancer Res 1994; 54:2378-2385.
16. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer, analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343:78-85.
17. Shields PG, Harris CC. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 2000; 18:2309-2315.
18. Wood RD, Mitchell M, Lindahl T. Human DNA repair genes, 2005. Mutat Res 2005; 577:275-283.
19. Bartkova J, Horejsi Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005; 434:864-870.
20. Gorgoulis VG, Vassiliou L-VF, Karakaidos P, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005; 434:907-913.
21. Matta JL, Villa JL, Ramos JM, et al. DNA repair and nonmelanoma skin cancer in Puerto Rican populations. J Am Acad Dermatol 2003; 49:433-439.
22. Sturgis EM, Clayman GL, Guan Y, Guo Z, Wei Q. DNA repair in lymphoblastoid cell lines from patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 1999; 125:185-190.
23. Orlow I, Park BJ, Mujumdar U, et al. DNA damage and repair capacity in patients with lung cancer: Prediction of multiple primary tumors. J Clin Oncol 2008; 26:3560-3566.
24. Ramos JM, Ruiz A, Colen R, Lopez ID, Grossman L, Matta JL. DNA repair and breast carcinoma susceptibility in women. Cancer 2004; 100:1352-1357.
25. Matta J, Echenique M, Negron E, et al. The association of DNA Repair with breast cancer risk in women. A comparative observational study. BMC Cancer 2012; 12:490.
26. Kennedy DO, Agrawal M, Shen J, et al. DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer. J Natl Cancer Inst 2005; 97:127-132.
27. de Laat WL, Jaspers NGJ, Hoeijmakers JHJ. Molecular mechanism of nucleotide excision repair. Genes Dev 1999; 13:768-785.
28. de Boer J, Hoeijmakers JHJ. Nucleotide excision repair and human syndromes. Carcinogenesis 2000; 21:453-460.
29. Cleaver JE, Lam ET, Revet I. Disorders of nucleotide excision repair: The genetic and molecular basis of heterogeneity. Nat Rev Genet 2009; 10:756-768.
30. Latimer JJ, Johnson JM, Kelly CM, et al. Nucleotide excision repair deficiency is intrinsic in sporadic stage I breast cancer. Proc Natl Acad Sci USA 2010; 107:21725-21730.
31. Li D, Wang M, Dhingra K, Hittelman WN. Aromatic DNA adducts in adjacent tissues of breast cancer patients: Clues to breast cancer etiology. Cancer Res 1996; 56:287-293.
32. Braithwaite E, Wu X, Wang Z. Repair of DNA lesions induced by polycyclic aromatic hydrocarbons in human cell-free extracts: Involvement of two excision repair mechanisms in vitro. Carcinogenesis 1998; 19:1239-1246.
33. Gammon MD, Santella RM, Neugut AI, et al. Environmental toxins and breast cancer on Long Island. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev 2002; 11:677-685.
34. Gammon MD, Sagiv SK, Eng SM, et al. Polycyclic aromatic hydrocarbon, DNA adducts and breast cancer: A pooled analysis. Arch Environ Health 2004; 59:640-649.
35. Crew KD, Gammon MD, Terry MB, et al. Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2007; 16:2033-2041.
36. Smith TR, Levine EA, Perrier ND, et al. DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12:1200-1204.
37. Shen J, Desai M, Agrawal M, et al. Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer. Cancer Epidemiol Biomarkers Prev 2006; 15:1614-1619.
38. Kumar R, Höglund L, Zhao C, Försti A, Snellman E, Hemminki K. Single nucleotide polymorphisms in the XPG gene: Determination of role in DNA repair and breast cancer risk. Int J Cancer 2003; 103:671-675.
39. Terry MB, Gammon MD, Zhang FF, et al. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2004; 13:2053-2058.
40. Justenhoven C, Hamann U, Pesch B, et al. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol Biomarkers Prev 2004; 13:2059-2064.
41. Zhang L, Zhang Z, Yan W. Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin Chim Acta 2005; 359:150-155.
42. Brewster AM, Jorgensen TJ, Ruczinski I, et al. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): Relationship to breast cancer risk and familial predisposition to breast cancer. Breast Cancer Res Treat 2006; 95:73-80.
43. Bai Y, Xu L, Yang X, et al. Sequence variations in DNA repair gene XPC is associated with lung cancer risk in a Chinese population: A case-control study. BMC Cancer 2007; 7:1-9.
44. Chang JS, Wrensch MR, Hansen HM, et al. Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer 2008; 123:2095-2104.
45. Mechanic LE, Millikan RC, Player J, et al. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: A population-based case control study. Carcinogenesis 2006; 27:1377-1385.
46. Forsti A, Angelini S, Festa F, et al. Single nucleotide polymorphisms in breast cancer. Oncol Rep 2004; 11:917-922.
47. Purcell S, Neale B, Todd-Brown K, et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-575.
48. Lin J, Swan GE, Shields PG, et al. Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: Genotype-phenotype correlation. Cancer Epidemiol Biomarkers Prev 2007; 16:2065-2071.
49. Qiao Y, Spitz MR, Shen H, et al. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis 2002; 23:295-299.
50. 1000 Genomes Project Consortium. An integrated map of genetic variation from 1, 092 human genomes. Nature 2012; 491:56-65. 1000Genomes web browser: browser.1000genomes.org/ (accessed April 16, 2013).
51. Pan J, Lin J, Izzo JG, et al. Genetic susceptibility to esophageal cancer: The role of the nucleotide excision repair pathway. Carcinogenesis 2009; 30:785-792.
52. Shen M, Berndt SI, Rothman N, et al. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer 2005; 116:768-773.
53. Landi S, Gemignani F, Canzian F, et al. DNA repair and cell cycle control genes and the risk of young-onset lung cancer. Cancer Res 2006; 66:11062-11069.
54. McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, et al. Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev 2009; 18:1118-1126.
55. Lin J, Pu X, Wang W, et al. Case control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma. Carcinogenesis 2008; 29:2112-2119.
56. Spitz MR, Wu X, Wang Y, et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 2001; 61:1354-1357.
57. Seker H, Butkiewicz D, Bowman ED, et al. Functional significance of XPD polymorphic variants: Attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype. Cancer Res 2001; 61:7430-7434.
58. Laine JP, Mocquet V, Bonfanti M, Braun C, Egly JM, Brousset P. Common XPD (ERCC2) polymorphisms have no measurable effect on nucleotide excision repair and basal transcription. DNA Repair 2007; 6:1264-1270.
59. Hou S-M, Fält S, Angelini S, et al. The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 2002; 23:599-603.
60. Shi Q, Wang L-E, Bondy ML, Brewster A, Singletary SE, Wei Q. Reduced DNA repair of benzoapyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis 2004; 25:1695-1700.
61. Matullo G, Palli D, Peluso M, et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects. Carcinogenesis 2001; 22:1437-1445.
62. Duell EJ, Wiencke JK, Cheng T-J, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000; 21:965-971.
63. Suarez-Martinez EB, Ruiz A, Matias J, et al. Early-onset of sporadic basal-cell carcinoma: Germline mutations in the TP53, PTCH, and XPD genes. P R Health Sci J 2007; 26:349-354.
64. Wang F, Chang D, Hu F-L, et al. DNA repair gene XPD polymorphisms and cancer risk: A meta-analysis based on 56 case-control studies. Cancer Epidemiol Biomarkers Prev 2008; 17:507-517.
65. Pastorelli R, Cerri A, Mezzetti M, Consonni E, Airoldi L. Effect of DNA repair gene polymorphisms on BPDE-DNA adducts in human lymphocytes. Int J Cancer 2002; 100:9-13.
66. Zhou W, Liu G, Miller DP, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12:359-365.
67. Popanda O, Schattenberg T, Phong CT, et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 2004; 25:2433-2441.
68. Liu Y, Scheurer ME, El-Zein R, et al. Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev 2009; 18:204-214.
69. Albain KS, Unger JM, Crowley JJ, Coltman CA, Hershman DL. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst 2009; 101:984-992.
70. Joslyn SA, West MM. Racial differences in breast carcinoma survival. Cancer 2000; 88:114-123.
71. Wojcik BE, Spinks MK, Optenberg SA. Breast carcinoma survival analysis for African American and White women in an equal-access health care system. Cancer 1998; 82:1310-1318.
72. Jacobellis J, Cutter G. Mammography screening and differences in stage of disease by race/ethnicity. Am J Public Health 2002; 92:1144-1150.